DNA & RNA Banking Services Market to Grow at CAGR of 7.29% through 2030

Advancements in genomic research and Rising Awareness of Genetic Disorders are expected to drive the Global DNA & RNA Banking Services Market growth in the forecast period, 2026-2030

According to TechSci Research report, “DNA & RNA Banking Services Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2020-2030F”, the Global DNA & RNA Banking Services Market stood at USD 7.97 Billion in 2024 and is expected to reach USD 12.18 Billion by 2030 with a CAGR of 7.29% during the forecast period.

The growing demand for personalized medicine is a pivotal driver of the global DNA and RNA banking services market, signaling a shift from conventional, generalized treatments to therapies tailored to individual genetic profiles. This evolution reflects the critical role of genetic material banking in advancing personalized healthcare solutions, particularly in fields such as oncology and rare genetic disorders, where precise genetic information is essential for developing targeted and effective treatments.

In oncology, for example, the identification of specific genetic mutations enables the development of therapies that significantly improve treatment efficacy while reducing adverse effects. Similarly, in rare genetic disorders, deep insights into genetic causes facilitate the creation of specialized therapies tailored to the unique needs of affected patients. This growing reliance on genetic profiling has amplified the demand for high-quality DNA and RNA samples, which are vital for understanding disease predispositions, treatment responses, and therapeutic outcomes.

Healthcare providers, pharmaceutical companies, and research institutions are increasingly investing in advanced biobanking solutions to support personalized medicine initiatives. These investments aim to enhance their capabilities in leveraging genetic data, accelerating the development of innovative therapies, and improving patient care. By integrating genetic information into clinical workflows, stakeholders can achieve superior patient outcomes while addressing unmet medical needs. As such, DNA and RNA banking services are becoming indispensable in driving innovation and maintaining a competitive edge in the healthcare landscape.

Regulatory and ethical frameworks are playing a critical role in fostering the growth of the DNA and RNA banking services market. Governments and regulatory bodies worldwide are establishing clear guidelines for the collection, storage, and utilization of genetic materials, ensuring transparency and compliance with ethical standards. These measures build public trust and encourage donor participation, which is crucial for the sustained expansion of biobanking services. Ethical considerations, such as protecting donor privacy and ensuring informed consent, further reinforce the credibility of biobanking practices. This regulatory and ethical foundation not only bolsters public confidence but also promotes collaborations between biobanks, healthcare providers, and research organizations. Together, these factors are creating a robust infrastructure to support the ongoing advancement of personalized medicine, positioning the DNA and RNA banking services market for sustained growth and innovation.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global DNA & RNA Banking Services Market”

The Global DNA & RNA Banking Services Market is segmented into type, application, end use, regional distribution, and company

Based on End Use, In the Global DNA & RNA Banking Services Market, Pharmaceutical & Biotechnology Companies are currently the dominant end users. This dominance can be attributed to the significant role these companies play in the research and development of new drugs and therapies, which heavily rely on genetic information. As the biopharmaceutical industry continues to expand, driven by the need for innovative treatments, the demand for high-quality DNA and RNA samples has surged.

Pharmaceutical and biotechnology companies utilize DNA and RNA banking services to obtain essential genetic materials for various applications, including drug discovery, clinical trials, and personalized medicine initiatives. These organizations require reliable access to a diverse range of genetic samples to conduct research on genetic variations and their implications for drug efficacy and safety. The ability to analyze genetic data enables these companies to identify potential therapeutic targets, optimize drug formulations, and develop targeted therapies tailored to specific patient populations.

Based on region, Europe is the second dominant region in the Global DNA & RNA Banking Services Market. Several factors contribute to Europe's strong presence in this market: Europe boasts a network of renowned research institutions and universities that focus on genetic research and biobanking. Countries such as the United Kingdom, Germany, France, and the Netherlands are home to leading academic and research organizations that are actively involved in genomic studies, driving the demand for DNA and RNA banking services.

European governments have recognized the importance of genetic research and biobanking in improving healthcare outcomes. Numerous funding programs and initiatives have been established to support research in genomics and biotechnology, promoting the development of biobanks across the region. Europe has a well-defined regulatory framework governing biobanking activities, ensuring ethical standards and compliance in handling genetic materials. This regulatory environment fosters public trust and encourages participation in biobanking initiatives, further enhancing the market. The increasing awareness of genetic disorders and the benefits of genetic testing among healthcare professionals and the public is driving the demand for biobanking services. This trend is particularly evident in countries with established healthcare systems, where genetic screening and diagnostics are becoming more prevalent.

Major companies operating in Global DNA & RNA Banking Services Market are:

• DNA Genotek Inc
• EasyDNA
• 23andMe, Inc.
• Biobanking.com
• US Biolab Corporation, Inc
• ProteoGenex
• Thermo Fisher Scientific, Inc.
• deCODE genetics
• Azenta Life Sciences
• Infinity BiologiX LLC (Sampled)

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Emerging markets are becoming increasingly significant in the Global DNA & RNA Banking Services Market, reflecting the broader trends of economic growth and technological advancement in regions such as Asia, Latin America, and Africa. As these countries witness improvements in their economic landscapes, there is a growing interest in genetic research, which is being supported by enhanced funding and governmental initiatives aimed at bolstering healthcare infrastructure. Investments in research initiatives are encouraging academic institutions and private organizations to establish biobanks, creating a more robust ecosystem for genetic material collection and storage. Globalization has played a crucial role in facilitating knowledge sharing and collaboration among researchers, healthcare providers, and biobank operators across borders. This interconnectedness enables the exchange of best practices and technological advancements, enhancing the capabilities of emerging biobanks. Consequently, as these markets continue to mature, the demand for DNA and RNA banking services will inevitably expand, driven by both local needs for personalized medicine and international research collaborations. The result is a diversified and dynamic market landscape where emerging markets contribute significantly to the overall growth of the global DNA & RNA banking services sector, increasing the accessibility of genetic materials for vital research and clinical applications”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“DNA & RNA Banking Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage, Others), By Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Others), By End Use (Academic Research, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Others), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global DNA & RNA Banking Services Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global DNA & RNA Banking Services Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com